Management of cerebral aneurysms in autosomal dominant polycystic kidney disease

Journal of the American Society of Nephrology

Volumn 13, Issue 1, 2002, Pages 269-276

  Pirson, Y ^a   Chauveau, D ^a   Torres, V ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CODEINE; DEXTROPROPOXYPHENE; PARACETAMOL;

ANEURYSM CLIP; ANEURYSM RUPTURE; ANGIOGRAPHY; ARTICLE; ARTIFICIAL EMBOLISM; AUTOSOMAL DOMINANT DISORDER; BRAIN ARTERY ANEURYSM; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; COST UTILITY ANALYSIS; HEADACHE; HUMAN; INTERMETHOD COMPARISON; KIDNEY POLYCYSTIC DISEASE; LUMBAR PUNCTURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0036139004     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Intracranial aneurysms in autosomal dominant polycystic disease
2. Value of magnetic resonance angiography for the detection of intracranial aneurysms in autosomal dominant polycystic kidney disease
3. Occult intracranial aneurysms in polycystic kidney disease: Screening with MR angiography
4. Intracranial aneurysms in autosomal dominant polycystic kidney disease
5. Prevalence and risk of rupture of intracranial aneurysms. A systematic review
6. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains
7. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein
8. PKD1 interacts with PKD2 through a probable coiled-coil domain
9. Polycystin 1 is required for the structural integrity of blood vessels
10. Cardiac defects and renal failure in mice with targeted mutations in Pkd2
11. Vascular expression of polycystin
12. Vascular expression of polycystin-2
13. The vasculopathy of autosomal dominant polycystic kidney disease: Insights from animal models
14. Intracranial aneurysms in autosomal dominant polycystic kidney disease
15. Intracranial aneurysms in polycystic kidney disease linked to chromosome 4
16. Mutation detection of PKD1 identifies a novel mutation common to three families with aneurysms and/or very-early-onset disease
17. Familial intracranial aneurysms
18. Familial intracranial aneurysms
19. Intracranial aneurysms
20. Influence of smoking, hypertension and sex on the phenotypic expression of familial intracranial aneurysms in siblings
21. Saccular intracranial aneurysms in autosomal dominant polycystic kidney disease
22. Extrarenal manifestations in autosomal dominant polycystic kidney disease
23. Avoiding pitfalls in the diagnosis of subarachnoid hemorrhage
24. Subarachnoid haemorrhage in ADPKD patients: How to recognize and how to manage?
25. Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: How to diagnose and who to screen?
26. Spontaneous vertebral artery dissection as a complication of autosomal dominant polycystic kidney disease
27. Spontaneous artery dissection: Is it part of the spectrum of autosomal dominant polycystic kidney disease?
28. Spinal meningeal diverticula in autosomal dominant polycystic kidney disease
29. Chronic subdural hematoma in autosomal dominant polycystic kidney disease
30. Subarachnoid hemorrhage: Aneurysm detection and preoperative evaluation with CT angiography
31. Subarachnoid hemorrhage
32. Treatment of intracranial ICA by embolization with coils. A systematic review
33. Ruptured intracranial aneurysms: Acute endovascular treatment with electrolytically detachable coils - A prospective randomized study
34. Endovascular treatment of multiple intracranial aneurysms by using Guglielmi detachable coils
35. Recurrent rupture of intracranial aneurysms in autosomal dominant polycystic kidney disease
36. Natural history of unruptured intracranial aneurysms: A long-term follow-up study
37. Recommendations for the management of patients with unruptured intracranial aneurysms. A statement for healthcare professionals from the Stroke Council of the American Heart Association
38. Which unruptured cerebral aneurysms should be treated? A cost-utility analysis
39. Unruptured intracranial aneurysm: Risks of rupture and risks of surgical intervention
40. Follow-up of intracranial aneurysms in autosomal dominant polycystic kidney disease by magnetic resonance angiography
41. Blinded prospective evaluation of sensitivity of MR angiography to known intracranial aneurysms: Importance of aneurysm size
42. Mortality and morbidity of surgery for unruptured intracranial aneurysms
43. Surgical and endovascular treatment of unruptured cerebral aneurysms at university hospitals
44. Endovascular and surgical treatment of unruptured cerebral aneurysms: Comparison of risks
45. Embolization of incidental cerebral aneurysms by using the Guglielmi detachable coil system
46. Risks and benefits of screening for intracranial aneurysms in first-degree relatives of patients with sporadic subarachnoid hemorrhage
47. Occult intracranial aneurysms in polycystic kidney disease: When is cerebral arteriography indicated?
48. Patients with polycystic kidney disease would benefit from routine magnetic resonance angiographic screening for intracerebral aneurysms: A decision analysis
49. Coiling, clipping, or medical management of unruptured intracranial aneurysms: Time to randomize?